Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 427 results found since Jan 2013.

Norovirus Is on the Rise. What to Know About Symptoms and Treatment
While SARS-CoV-2 has dominated headlines for the past few years, other viruses have been simmering in the background. And with most of COVID-19’s infection control measures (like mask-wearing, isolation, and physical distancing) now gone in the U.S., those viruses are starting to roar back again. The U.S. has already seen spikes in RSV and influenza, and now norovirus cases are inching upward, according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC). Unlike SARS-CoV-2, RSV, and influenza, norovirus is not a respiratory pathogen but instead causes problems in the gastrointestinal tra...
Source: TIME: Health - February 10, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Public Health Source Type: news

Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022
DISCUSSION: This review of reports to VAERS following co-administration of mRNA COVID-19 and seasonal influenza vaccines did not reveal any unusual or unexpected patterns of AEs. Increased reporting of certain events (e.g., COVID-19 disease) was expected. CDC will continue to monitor the safety of co-administration of mRNA COVID-19 and seasonal influenza vaccines, including co-administration involving bivalent mRNA COVID-19 booster vaccines that have been recommended for people ages ≥ 6 months in the United States.PMID:36669964 | DOI:10.1016/j.vaccine.2022.12.069
Source: Vaccine - January 20, 2023 Category: Allergy & Immunology Authors: Pedro L Moro Bicheng Zhang Carol Ennulat Margaret Harris Rachel McVey Gina Woody Paige Marquez Michael M McNeil John R Su Source Type: research

Investigation on the hesitancy of COVID-19 vaccination among liver transplant recipients: A cross-sectional study in China
CONCLUSION: For liver transplant recipients, COVID-19 vaccine is an important preventive measure. Identifying the factors influencing COVID-19 vaccine hesitancy is therefore critical to developing a promotion plan. Our study shows that more comprehensive vaccine knowledge popularization and relevant medical workers' training can effectively improve the acceptance of COVID-19 vaccine in this population.PMID:36589975 | PMC:PMC9797997 | DOI:10.3389/fpubh.2022.1014942
Source: Pain Physician - January 2, 2023 Category: Anesthesiology Authors: Yixiao Pan Shiming Gong Xinye Zhu Chuqing Xue Yilei Jing Yinghua Sun Yongbing Qian Jianjun Zhang Qiang Xia Source Type: research

Fight Aging! Newsletter, January 2nd 2023
In conclusion, circulating monocytes in older adults exhibit increased expression of activation, adhesion, and migration markers, but decreased expression of co-inhibitory molecules. MERTK Inhibition Increases Bone Density via Increased Osteoblast Activity https://www.fightaging.org/archives/2022/12/mertk-inhibition-increases-bone-density-via-increased-osteoblast-activity/ Bone density results from the balance of constant activity on the part of osteoblasts and osteoclasts, the former building bone, the latter breaking it down. With advancing age, the balance of activity shifts to favor osteoclasts, prod...
Source: Fight Aging! - January 1, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

A Look Back at 2022: Progress Towards the Treatment of Aging as a Medical Condition
At the end of 2022, we can reflect on the fact that we are steadily entering a new era of medicine, one in which mechanisms of aging are targeted rather than ignored. It is a profound change, one that will change the shape of a human life and ultimately the human condition by eliminating the greatest sources of suffering and death in the world. Year after year, we see increased funding, ongoing progress towards therapies capable of slowing aging or reversing aspects of aging, and a growing taxonomy of such potential therapies and their target mechanisms. The view of aging in the medical community and public at large...
Source: Fight Aging! - December 30, 2022 Category: Research Authors: Reason Tags: Of Interest Source Type: blogs

Going Viral
Helen Bramwell of StatNews is an excellent writer about public health. Here she interviews a bunch of scientists to ask what surprised them about Covid19.  It ' s a long read, and I won ' t try to summarize it all, but a couple of points stand out.The first is that most experts originally thought, based on experience with other coronaviruses, that this one would be stable -- that it would not be able to mutate so as to avoid immunity from previous infections or vaccination. Therefore they believed that the pandemic would peak after a few months and we ' d enter an endemic phase. (You might remember those models from t...
Source: Stayin' Alive - December 30, 2022 Category: American Health Source Type: blogs

A case of giant primary splenic hydatid cyst: Case report
We present a case of 29-year male patient from rural areas presented with the complain of left hypochondriac pain and tenderness along with the history of farming and cattle raising. There was no other significant history.CLINICAL FINDINGS AND INVESTIGATIONS: Physical examination showed mildly distended abdomen, mild tenderness over left hypochondrium. Routine laboratory investigations were sent. Ultrasound and CT scan of the abdomen showed giant splenic cyst measuring approx. 15 × 14 × 11 cm along with daughter cysts. Postoperatively, cyst was sent for histopathological examination.INTERVENTION AND OUTCOME: Preoperative...
Source: Annals of Medicine - December 30, 2022 Category: Internal Medicine Authors: Sampurna Singh Shreeja Kisee Suprabha Amatya Santosh Singh Shiwani Bista Rajan Shrestha Milan Kumar Chhantel Thapa Source Type: research

Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting
Curr Pain Headache Rep. 2022 Nov 23. doi: 10.1007/s11916-022-01094-y. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: The aim of this review is to characterize headache as a vaccine adverse event (VAE) in clinical trials.RECENT FINDINGS: Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13 infectious agents). The median rate (interquartile range) of headache was 15.6% (IQR: 9.6-37.6%). Of these, 24.5% of the RCTs reported headache greater in the vaccine group compared to the placebo/control group. In the herpes zoster vaccination trials, headache was more common in all active groups: me...
Source: Herpes - November 23, 2022 Category: Infectious Diseases Authors: Kimberly N Garces Alexandra N Cocores Peter J Goadsby Teshamae S Monteith Source Type: research

We Need to Bring Sexual Health Care to Places Where People Have Sex
On Saturday, June 29, 2019, a group of over 200 queer and trans folks were gathered in New York City, celebrating the city’s big World Pride weekend. They had all come to a party called NYC Inferno known for sexual activity. At around midnight, they were gathered in the front of the venue, rapt as an artist led them in an interactive performance. Within moments, everyone was singing the refrain: “We’ve got to keep each other alive, because no one else is gonna do it.” With this care-based ethos in mind, NYC Inferno, and all other queer sex-based venues in NYC, quickly shut down in July 2022, when Mo...
Source: TIME: Health - November 19, 2022 Category: Consumer Health News Authors: Joseph Osmundson, Adam Baran, and Ted Long Tags: Uncategorized freelance health Health Care LGBTQ Source Type: news

Acute Retinal Pigment Epitheliitis following Vaccination
We present a rare case of acute retinal pigment epitheliitis (ARPE) following vaccination. An 18-year-old Japanese man visited our hospital with a 5-day history of a central scotoma in the right eye. He had received the second dose of coronavirus disease 2019 vaccination (BNT162b2 mRNA, Pfizer-BioNTech) 1 month prior, following which he developed a low-grade fever of 37.3 –37.5°C for 2 days accompanied by joint pain. Although he had received influenza vaccination 5 days prior to this presentation, no systemic symptoms other than injection site pain were observed. Blood test results were unremarkable. Ophthalmological ex...
Source: Case Reports in Ophthalmology - November 10, 2022 Category: Opthalmology Source Type: research

Association of post ‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial
ConclusionMild to moderate post-vaccination reactions after influenza vaccine were associated with reduced risk of cardiopulmonary hospitalizations and all-cause mortality in patients with high-risk cardiovascular disease, while severe reactions may indicate increased risk. Mild to moderate AR to influenza vaccination may be a marker of immune response and should not deter future vaccinations.
Source: European Journal of Heart Failure - November 7, 2022 Category: Cardiology Authors: Alexander Peikert, Brian L. Claggett, KyungMann Kim, Jacob A. Udell, Jacob Joseph, Akshay S. Desai, Michael E. Farkouh, Sheila M. Hegde, Adrian F. Hernandez, Deepak L. Bhatt, J. Michael Gaziano, H. Keipp Talbot, Clyde Yancy, Inder Anand, Lu Tags: Research Article Source Type: research